Akers Biosciences Announces Q3 2017 Earnings
15 nov. 2017 07h00 HE
|
Akers Biosciences Inc
Revenues up 10% as Breathalyzers and Cholesterol Tests Begin to Contribute THOROFARE, N.J, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L),...
Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Third Quarter 2017 Financial Results
07 nov. 2017 08h00 HE
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary,...